Physician profile
Paul Norio Morton
NPI 1669736989
$82,616.71
in general payments reported to CMS, 2019-2025
37 companies · $43K in 2025
The $43K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,944 · 2020: $1,510 · 2021: $13K · 2022: $4,765 · 2023: $8,476 · 2024: $6,369 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $26K · Debt Forgiveness: $25K · Food and Beverage: $7,035 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $25,982.92 |
| Debt Forgiveness | $24,550.00 |
| Food and Beverage | $7,035.13 |
| Education | $284.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $29,293.13 | 2019-2025 | Persona, Rosa, Comprehensive Shoulder System |
| Orthofix Medical, INC. | $28,857.26 | 2021-2025 | Physio-Stim, Accelstim |
| Smith+Nephew, INC. | $8,388.11 | 2019-2025 | Acufex Meniscal Root Repair, Novostitch, Q-Fix |
| Globus Medical, INC. | $5,403.20 | 2021-2025 | Autobahn, Precice Intramedullary Limb Lengthening System, Autobahn |
| Sonex Health, INC. | $2,040.72 | 2025 | Sx-One Microknife |
| Vericel Corporation | $2,032.41 | 2025 | Maci |
| Stryker Corporation | $1,252.05 | 2019-2025 | Mako, Procinch |
| Think Surgical, INC. | $928.19 | 2019 | |
| Depuy Synthes Sales INC. | $608.42 | 2019-2025 | Velys, Na, Tfn-Advance |
| Si-Bone, INC. | $550.79 | 2019-2024 | |
| Next Science LLC | $366.08 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $335.45 | 2022-2025 | Iovera, Zilretta, Exparel |
| Alphatec Spine, INC | $333.35 | 2021 | |
| Bioventus LLC | $235.42 | 2021-2025 | Stimrouter Implantable Kit, Xcell, Durolane |
| Episurf Medical, INC. | $191.09 | 2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $176.36 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Endeavor Orthopaedics LLC | $169.38 | 2025 | Summit Patella Plating System |
| Axogen | $144.04 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Medtronic, INC. | $139.52 | 2024 | Aquamantys(Tm) |
| Biom'Up France Sas | $133.30 | 2021 | |
| Aesculap Implant Systems, LLC | $125.00 | 2019 | |
| Osiris Therapeutics INC. | $120.41 | 2019 | |
| Onkos Surgical, INC. | $115.18 | 2019 | |
| Amgen INC. | $108.71 | 2021-2025 | Evenity |
| Kyowa Kirin, INC. | $88.30 | 2024 | |
| Heron Therapeutics, INC. | $82.46 | 2022-2024 | Zynrelef |
| Avanos Medical | $70.51 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $58.01 | 2025 | |
| Innovation Technologies INC | $46.00 | 2019 | |
| Curonix LLC | $42.92 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Dilon Technologies, INC. | $39.31 | 2025 | Hemoblast Bellows |
| Ferring Pharmaceuticals INC. | $25.99 | 2021 | |
| Biocomposites INC | $25.47 | 2019 | |
| Mimedx Group, INC. | $25.28 | 2025 | |
| Convatec INC. | $23.87 | 2020 | |
| Ethicon US, LLC | $21.38 | 2024 | Stratafix, Ethicon |
| Abbvie INC. | $19.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.